« Back
Home /
Methyldopa (hydrate)

Methyldopa (hydrate)

Manufacturer	MedChem Express
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Clone	N/A
Amount	1 g
Item no.	HY-B0225B-1g
Targets	Adrenergic Receptor
CASRN	41372-08-1
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	Methyldopa hydrate (L-(-)-α-Methyldopa hydrate), a potent antihyoertensive agent, is an alpha-adrenergic agonist (selective for α2-adrenergic receptors). Methyldopa hydrate is a proagent and is metabolized (α-Methylepinephrine) in the central nervous system[1][2].
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
Manufacturers Applications	COVID-19-immunoregulation
MolecularWeight	238.24
Clinical_Information	Launched
Manufacturers Research_Area	Cardiovascular Disease; Endocrinology
Solubility	DMSO : 25 mg/mL (ultrasonic)\|H2O : 1 mg/mL (ultrasonic)
Manufacturers Target	Adrenergic Receptor; Endogenous Metabolite
Isoform	α adrenergic receptor
Pathway	GPCR/G Protein; Metabolic Enzyme/Protease; Neuronal Signaling
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-B0225B-1g-safety-datasheet.pdf